United States· US:67877-922_2a51dd17-fedf-4168-be2a-337ab74667a8
Tolvaptan
A medicinal product, registered in United States by Ascend Laboratories, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Manufacturer
- Ascend Laboratories, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1167877-922-54
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ceef6ded-ce38-464c-af7d-53984dffa22a GET /v1/drugs/ceef6ded-ce38-464c-af7d-53984dffa22a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": null,
"source": "ndc",
"strength": null,
"substance": null,
"productndc": "67877-922",
"dosage_form": "KIT",
"dea_schedule": null,
"strength_unit": null,
"application_number": "ANDA220147",
"marketing_category": "ANDA"
}See everything about Tolvaptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.